Keyphrases
Mathematical Model
100%
Bladder Cancer
63%
Bacillus Calmette
52%
Bladder Cancer Therapy
38%
Interleukin-2
30%
Bladder
21%
Metastasis
20%
Superficial Bladder Cancer
18%
Stability Analysis
18%
Chronic Myeloid Leukemia
17%
Mathematical Modeling
17%
Bacillus Calmette-Guérin
15%
Cytarabine
15%
Bacillus
15%
Treatment Protocol
15%
Imatinib
14%
Tumor-free
14%
Treatment Model
14%
Leukemic Cells
13%
Spatiotemporal
13%
Chemotherapy
13%
Numerical Simulation
12%
Intervention Policies
12%
Cancer Cells
12%
Non-muscle Invasive Bladder Cancer (NMIBC)
11%
Immune Response
10%
Tumor
10%
PDE Modeling
10%
Ibrutinib
10%
Chronic Lymphocytic Leukemia
10%
Breast Cancer
10%
Urothelium
9%
Clinical Data
9%
PDE
9%
Mathematical Analysis
9%
COVID-19 Pandemic
8%
Equilibrium State
8%
Vaccination
8%
COVID-19
8%
Tumor Size
7%
Immune System
7%
Combination Therapy
7%
Logistic Growth
7%
Primary Tumor
7%
Optimal Treatment
7%
Tumor-immune Interaction
7%
Treatment Optimization
7%
Non-pharmaceutical Interventions
7%
Biological Markers
7%
Drug Efficacy
7%
Medicine and Dentistry
Bladder Cancer
44%
Immunotherapy
33%
Neoplasm
24%
Metastatic Carcinoma
23%
Cancer Therapy
18%
Interleukin 2
14%
Superficial Bladder Cancer
14%
Bladder
13%
Invasive Bladder Cancer
11%
Malignant Neoplasm
10%
Ibrutinib
10%
Cytarabine
10%
Mycobacterium Bovis BCG
10%
COVID-19
10%
Primary Tumor
8%
In Vitro
8%
Immunity
8%
Carcinogen
8%
Tumor Progression
8%
Leukemia
7%
Urothelium
7%
Side Effect
7%
B-Cell Chronic Lymphocytic Leukemia
7%
Colorectal Carcinoma
7%
Immune Response
6%
Bladder Carcinoma
6%
Cancer Growth
6%
Metastatic Colorectal Cancer
5%
Biological Marker
5%
Personalized Medicine
5%
Drug Efficacy
5%
Non Muscle Invasive Treatment of Bladder Cancer
5%
Imatinib
5%
Cell Death
5%
Infection
5%
Acute Kidney Injury
5%
Mitomycin
5%
Partial Nephrectomy
5%
Lung Cancer
5%
Incyclinide
5%
Cancer Test
5%
Cytotoxic Agent
5%